AK006 is a humanized IgG1 monoclonal antibody agonist targeting sialic acid-binding immunoglobulin-like lectin 6 (Siglec-6). It effectively inhibits IgE-mediated activation of human mast cells. AK006 is applicable in the study of inflammatory diseases such as chronic urticaria (CU) and asthma.
Target-Kategorie:
Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
